Enliven Therapeutics, Inc. (ELVN) Insider Traders

$22.29

$0.43 (1.97%)
Last update: 04:00 PM EST
Day's range
$21.28
Day's range
$22.52

Enliven Therapeutics, Inc. Insider Transactions

500000050000004000000400000030000003000000200000020000001000000100000000Oct 2024Oct 2024Nov 2024Nov 2024Dec 2024Dec 2024Jan 2025Jan 2025Feb 2025Feb 2025Mar 2025Mar 2025Apr 2025Apr 2025May 2025May 2025
Purchase
Sell

Enliven Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Sell 5,000 @ $16.49 $82.45 K 972,892 05/19/2025 05/21/2025
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 5,000 @ $16.31 $81.53 K 985,188 05/19/2025 05/21/2025
Patel Anish

CHIEF OPERATING OFFICER

Sell 104 @ $19.87 $2.07 K 309,976 05/07/2025 05/09/2025
Patel Anish

CHIEF OPERATING OFFICER

Sell 390 @ $19.40 $7.57 K 310,080 05/07/2025 05/09/2025
Patel Anish

CHIEF OPERATING OFFICER

Sell 6,173 @ $18.30 $112.95 K 310,470 05/07/2025 05/09/2025
Sell 2,170 @ $20.00 $43.41 K 977,892 05/02/2025 05/05/2025
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 2,470 @ $20.01 $49.42 K 990,188 05/02/2025 05/05/2025
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 5,030 @ $20.07 $100.97 K 992,658 05/01/2025 05/05/2025
Sell 5,330 @ $20.08 $107.01 K 980,062 05/01/2025 05/05/2025
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 3,181 @ $18.68 $59.42 K 23,069 04/28/2025 04/30/2025
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 69 @ $19.12 $1.32 K 23,000 04/28/2025 04/30/2025
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 330 @ $16.72 $5.52 K 997,688 04/21/2025 04/23/2025
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 4,670 @ $16.03 $74.85 K 998,018 04/21/2025 04/23/2025
Sell 5,000 @ $16.42 $82.10 K 985,392 04/17/2025 04/21/2025
Patel Anish

CHIEF OPERATING OFFICER

Sell 148 @ $19.27 $2.85 K 316,643 04/07/2025 04/09/2025
Patel Anish

CHIEF OPERATING OFFICER

Sell 2,763 @ $18.29 $50.53 K 316,791 04/07/2025 04/09/2025
Patel Anish

CHIEF OPERATING OFFICER

Sell 3,756 @ $17.81 $66.89 K 319,554 04/07/2025 04/09/2025
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 3,250 @ $21.33 $69.32 K 23,000 03/27/2025 03/31/2025
Hohl Benjamin

CHIEF FINANCIAL OFFICER

Sell 1,000 @ $22.50 $22.51 K 23,000 03/24/2025 03/26/2025
Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

Sell 12,500 @ $20.61 $257.58 K 1,002,688 03/19/2025 03/21/2025
Showing 1 to 20 of 64 results
Page 1 of 4

Enliven Therapeutics, Inc. FAQ's

The list of insiders at Enliven Therapeutics, Inc. includes Lyssikatos Joseph P, Kintz Samuel, Hohl Benjamin, Heyman Richard A., Ballal Rahul D., Patel Anish, Collins Helen Louise.

Insiders have sold a total of 286.34 K Enliven Therapeutics, Inc. shares in the last 12 months for a total of 7.01 M sold.

The following insiders have sold Enliven Therapeutics, Inc. shares in the last 12 months: Lyssikatos Joseph P ($2.33 M), Kintz Samuel ($1.87 M), Hohl Benjamin ($1.10 M), Heyman Richard A. ($159.95 K), Ballal Rahul D. ($293.56 K), Patel Anish ($1.24 M), Collins Helen Louise ($24.48 K),